PT Medikaloka Hermina TbkISX:HEAL -2.14%72 ROE % is 7.11% as of Mar. 2026, which is 40% below its 10-year median of 11.91. GuruFocus rates ISX:HEAL with a GF Score™ of 72/100 and a GF Value™ of Rp1,580.69 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 624 Healthcare Providers & Services companies, PT Medikaloka Hermina Tbk ranks better than 54.33% on this metric.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PT Medikaloka Hermina Tbk's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medikaloka Hermina Tbk ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Medikaloka Hermina Tbk's ROE % distribution charts can be found below:
* The bar in red indicates where PT Medikaloka Hermina Tbk's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
PT Medikaloka Hermina Tbk (ISX:HEAL) has a ROE % of 7.11% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on PT Medikaloka Hermina Tbk and its competitors. This is 40% below median its historical median of 11.91. Over the past decade, PT Medikaloka Hermina Tbk's ROE % has ranged from 5.91 to 33.68. According to the industry distribution chart, PT Medikaloka Hermina Tbk ranks #285 out of 624 companies in the Healthcare Providers & Services industry, placing it in the top 45.7%.
Is PT Medikaloka Hermina Tbk's ROE % too high?
PT Medikaloka Hermina Tbk's current ROE % of 7.11% is 40% below median its 10-year median of 11.91. Over the past 10 years, this metric has ranged from a low of 5.91 to a high of 33.68. The Healthcare Providers & Services industry median ROE % is 5.85. PT Medikaloka Hermina Tbk's value of 7.11% is 21.5% above this industry median. Based on the distribution chart, PT Medikaloka Hermina Tbk ranks #285 out of 624 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Medikaloka Hermina Tbk ranks #285 out of 624 companies for ROE %. This puts PT Medikaloka Hermina Tbk in the upper half of its industry. The industry median ROE % is 5.85. PT Medikaloka Hermina Tbk's value of 7.11% is 21.5% above this benchmark. Historically, PT Medikaloka Hermina Tbk's own ROE % has ranged from 5.91 to 33.68 over the past decade. While the company's 10-year median is 11.91 vs. the industry median of 5.85, PT Medikaloka Hermina Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.85, based on 624 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medikaloka Hermina Tbk's current ROE % of 7.11% is 21.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on PT Medikaloka Hermina Tbk and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medikaloka Hermina Tbk's current ROE % is 7.11%, which is 40% below median its own 10-year median of 11.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,580.69, compared to a current price of Rp915.00 — trading 42.1% below its estimated fair value. The current ROE % is 7.11%, which is 40% below median its 10-year median of 11.91 and 21.5% above the Healthcare Providers & Services industry median of 5.85. PT Medikaloka Hermina Tbk's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current ROE % is 7.11% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp915.00 is trading 42.1% below its estimated GF Value™ of Rp1,580.69.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
ROE %: 7.11% (40% below median its 10-year median of 11.91)
GF Value™: Rp1,580.69 vs. price of Rp915.00 (42.1% below fair value)
Industry Position: 21.5% above the Healthcare Providers & Services median (#285 of 624)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
72GF Score
Get the complete analysis for ISX:HEAL
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
